The NeuroVista management team has a proven track-record of developing and commercializing innovative medical technologies that have a profound impact on healthcare. Unique domain expertise in the design and development of implantable neurological products, combined with a passion to improve the lives of people with debilitating conditions, has compelled this accomplished team to pursue the development of revolutionary technologies for the management and treatment of epilepsy.
John F. Harris
PRESIDENT AND CEO
John F. Harris is NeuroVista’s President and CEO and brings more than 20 years of experience successfully developing and commercializing innovative medical device technologies. Prior to joining NeuroVista in December of 2004, John was an Executive in Residence at Versant Ventures, a healthcare-dedicated venture capital firm, providing consulting on early-stage medical device opportunities.
Prior to Versant Ventures, John was a founder and the Vice President of Marketing and Business Development for Northstar Neuroscience, Inc., a Seattle-based medical device company seeking to improve neurological recovery following stroke through targeted electrical stimulation of the brain. Prior to Northstar, John was a founder of Heartstream, a Seattle-based company that revolutionized the treatment of sudden cardiac arrest with uniquely designed external defibrillators that make the deployment of these devices practical in a variety of settings. In addition to his founding role, John was a member of the executive team responsible for guiding the company through formation, product development, venture financing, Food and Drug Administration (FDA) clearance, product launch, manufacturing scale-up, an initial public offering, worldwide sales and distribution, and the sale of the company to Hewlett-Packard. The company is now owned by Philips Medical Systems.
John received a BS in industrial engineering from Stanford University and an MBA from Northwestern University's Kellogg School of Management.